Epstein Secrets

h the tireless work of the FBI-Bryan Resident Agency and NASA-OIG investigative teams,' said Penye K. Turner, FBI Houston Special Agent in Charge." Courthouse News <https://www.courthousenews.corn/professor-accused-of-hiding-ties-to-china-while-doing- nasa-researchk (8/24, Langford, 2K) , ICBTX-TV <https://www.k

t. On NBC Nightly News <https://playvideo.bulletinintelligence.corn/ed6acbba7a9f4e498e804748dcd439bf?pubid=fbi> (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are] cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Directo

, the Washington Times <https://www.washingtontimes.com/news/2020/nov/10/andrew-mccabe- full-responsibility-fisa-warrant-errk (11/10, Mordock, 492K), Courthouse News <https://www.courthousenews.corn/former-fbi-no-2-defends-trump-russia-probe/> (11/10, Jones, 2K), and Fox News (1 <https://www.foxnews.corn/politic

nt. On NBC Nightly News <https://playvideo.bulletinintelligence.comTheda8ce4e804a7f90ale70576d7c496? pubid=fbi> (11/11, story 3, 1:45, Holt, 5.8M), Tom Costello reported, "Receiving emergency FDA approval, Eli Lilly's new IV antibody treatment is similar to what President Trump received last month. Meant for

/10, Goldman, 18.61M), the New York Post (11/10, Bowden, 4.57M), the Daily Caller (11/10, Ross, 716K), the Washington Times (11/10, Mordock, 492K), Courthouse News (11/10, Jones, 2K), and Fox News (1. and 2). OPERATION LEGEND New Mexico To Receive $500K Crime-Fighting Grant. The Albuquerque (NM) Journal (11/1

med insufficiently loyal." FDA Grants Emergency Approval To Eli Lilly Antibody Treatment. On NBC Nightly NewsVI (11/11, story 3, 1:45, Holt, 5.8M), Tom Costello reported, "Receiving emergency FDA approval, Eli Lilly's new IV antibody treatment is similar to what President Trump received last month. Meant fo

the tireless work of the FBI- Bryan Resident Agency and NASA-OIG investigative teams,' said Perrye K. Turner, FBI Houston Special Agent in Charge." Courthouse News (8/24, Langford, 2K) , KBTX-TV College Station, TX (8/24, DeMoss, 91K) , and the Washington Examiner (8/24, Dunleavy, 448K) also report. Dozens Of

" Two of the three networks reported Monday night on the FDA's approval of the treatment. On NBC Nightly NewsVi (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are) cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Direct

nt's trial "is believed to be the first related to the insurrection since the Justice Department opened its sweeping investigation into the attack." Courthouse News (4/22, Pullano, 21K) also reports. New York Man Charged In Capitol Siege Probe. The Watertown (NY) Daily Times (4/22, Muir, 58K) reports that a s

ive against all of the variants identified so far." NBC Looks At Ongoing Child Vaccine Trials. On NBC Nightly NewsVi (4/22, story 10, 1:55, 4.83M), Tom Costello profiled two nine-year-old twins who "were the first [children) in the country to receive the Pfizer vaccine" as "part of a nationwide trial testin

/10, Goldman, 18.61M), the New York Post (11/10, Bowden, 4.57M), the Daily Caller (11/10, Ross, 716K), the Washington Times (11/10, Mordock, 492K), Courthouse News (11/10, Jones, 2K), and Fox News (1 and 2). OPERATION LEGEND New Mexico To Receive $500K Crime-Fighting Grant. The Albuquerque (NM) Journal (11/11

med insufficiently loyal." FDA Grants Emergency Approval To Eli Lilly Antibody Treatment. On NBC Nightly NewsVI (11/11, story 3, 1:45, Holt, 5.8M), Tom Costello reported, "Receiving emergency FDA approval, Eli Lilly's new IV antibody treatment is similar to what President Trump received last month. Meant fo

the tireless work of the FBI- Bryan Resident Agency and NASA-OIG investigative teams,' said Perrye K. Turner, FBI Houston Special Agent in Charge." Courthouse News (8/24, Langford, 2K) , KBTX-TV College Station, TX (8/24, DeMoss, 91K) , and the Washington Examiner (8/24, Dunleavy, 448K) also report. Dozens Of

" Two of the three networks reported Monday night on the FDA's approval of the treatment. On NBC Nightly NewsVi (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are) cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Direct